CLOs on the Move

American Board of Medical Specialties

www.abms.org

 
Established in 1933, the American Board of Medical Specialties (ABMS), a not-for-profit organization comprising 24 medical specialty Member Boards, is the pre-eminent entity overseeing the certification of physician specialists in the United States. The primary function of ABMS is to assist its Member Boards in developing and implementing educational and professional standards to evaluate and certify physician specialists. By participating in these initiatives, ABMS also serves as a unique and highly influential voice in the healthcare industry, bringing focus and rigor to issues involving specialization and certification in medicine. ABMS is a designated primary equivalent source of credential information.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.abms.org
  • 353 North Clark Street Suite 1400
    Chicago, IL USA 60654
  • Phone: 312.436.2600

Executives

Name Title Contact Details
Allison Lancaster
Assistant General Counsel Profile

Similar Companies

meQuilibrium

Resilience training for employers, health plans, and individuals to improve outcomes in stress management, productivity, health, and wellbeing.

CCS Assoc

CCS Assoc is a Mountain View, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Mid Coast Health Services

Mid Coast Health Services is one of the leading companies in Healthcare, Pharmaceuticals, & Biotech industry. Mid Coast Health Services is based in Brunswick, ME. You can find more information on Mid Coast Health Services at www.midcoasthealth.com

Alnylam

Alnylam is the world`s leading RNAi therapeutics company and the first and only company to bring an RNAi medicine to market. We are developing RNAi (RNA interference) as an innovative, entirely new class of medicines to treat rare genetic, cardio metabolic, acute hepatic infectious and central nervous system (CNS) and ocular diseases. Alnylam was founded in 2002 based on a Nobel Prize-winning breakthrough in biology – the discovery of RNAi, and a bold vision that this discovery could be used to silence disease-causing genes upstream of today`s medicines. We are relentless in our pursuit of new treatments because we believe that RNAi therapeutics can be used to treat many diseases for which treatment options do not exist or are inadequate. Overall, we believe that patients shouldn`t have to wait for hope. Alnylam is turning scientific possibility into reality - in 2018, the FDA and European EMA approved of our first product, ONPATTRO (patisiran) which is also the first-ever approved RNAi therapeutic. In 2019, the FDA approved our second product, GIVLAARI (givosiran). Our robust pipeline of investigational medicines includes multiple programs in late-stage and early-stage clinical development. We are a global and diverse company of more than 1,500 people. We pride ourself on fostering a fun, inclusive and dynamic work environment where employees can recognize their fullest potential. That`s why we`ve been named a Science Magazine Top Employer for two years in a row (`19-`20), a Boston Globe Top Place to Work 5x in a row (`15-`19) and one of Fast Company`s 50 Most Innovative Companies for 2019. We are based in Cambridge, U.S., with offices throughout Europe, Asia and South America.

Gateway Healthcare

Gateway Healthcare (GHI) is a non-profit behavioral health care organization that provides a wide array of services to adults, children and families in Rhode Island. We provide services to people of all cultural and economic backgrounds, who may not